Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review

ConclusionsThere is strong evidence that it is possible to improve oncologic outcomes without substantially increasing toxicity through MR-guided focal boost, at least in the setting of a 35-fraction radiotherapy regimen. Barriers to clinical practice implementation are addressable through additional investigation and new technologies.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research